Clinical Trial Update: A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating HCP1803 for efficacy and safety in essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• HCP1803

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Hypertension | Phase 3 | Status: COMPLETED